The DEA and Patient-Owned Meds: Susanna Herkert Breaks It Down
Episode Overview
DEA regulations prohibit patient-owned controlled substances from being given to another person
Facilities face compliance risks and potential diversion events with patient-owned meds
DEA allows exceptions for storing patient-owned meds in secure lockboxes in the patient's room
Proper documentation and committee decisions are crucial for handling patient-owned controlled substances
The DEA requires a detailed compliance approach to patient-owned meds, considering patient safety and facility policies
I think from DEA's standpoint, it's that, you know, if at all possible, they need to be using something that's on formulary at the hospital, that they should not be taking any of their personally owned controlled substances.
Imagine trying to manage a healthcare facility where patient-owned controlled substances are involved. It's a complex issue, one that Susanna Herkert, Senior Managing Director at Guidepost and former DEA Supervisory Diversion Investigator, tackles head-on in this episode. She dives into the often-confusing DEA regulations surrounding these medications and explains why they can be a ticking time bomb for any healthcare facility.
Herkert doesn't just outline the problems; she offers practical solutions, like secure lockboxes in patient rooms and the importance of meticulous documentation. If you're in the healthcare industry, you won't want to miss her expert advice on navigating these tricky waters. Herkert's insights make it clear that understanding and complying with DEA rules is crucial for both patient safety and facility integrity.